B.J. Rimel, MD of Cedars Sinai Medical Center discusses the future clinical trials in ovarian cancer from SGO 2016.
Transcription:
In terms of future clinical trials. There we are selecting more clinical trials based on. Known genetic predispositions be RCA. The potential response to platinum potential response to part now being a sort of thing that we’re looking at. So all of these panel testings are going to lead us down different pathways and so that does make us help a stratified patients for future study for clinical trials. Probably the direction I see that going on right now.
Advertisement